Ron Renaud

Outlook Zendesk

biotechnology research biopharmaceutical clinical-stage therapies obesity weight management glp-1 gip receptor dual agonist kai-9531 injectable oral therapies chronic weight management innovative treatments hypoglycemic injectable peptides oral peptides small molecule diabetes clinical trials phase 2 regulatory interactions safety profile patient empowerment medical research weight loss metabolic diseases therapeutic pipeline health care scientific studies preclinical development commercialization equity financing healthcare investments pharmaceutical innovation drug development corporate governance intellectual property biotechnology health solutions phase1 trials patient outcomes disease management clinical pharmacology medical advancements health equity federal regulations clinical evidence symptomatic treatment lifespan improvement aging health management medical health wellness & fitness hospital & health care